The Brain Tumour Charity is proud to announce unprecedented £10million funding for three pioneering research programmes. The programmes mark the start of a new era of research into brain tumours and aim to accelerate their progress towards defeating both adult and childhood brain tumours.
Grants from The Brain Tumour Charity totalling £5million will fund the research programmes and are being matched by other charitable and public sources. The milestone investment paves the way to transform the diagnosis and treatment of both childhood and adult brain tumours, the biggest cancer killer of people under 40.
Neil Dickson, Vice Chair of The Brain Tumour Charity, said: “This level of spending on brain tumour research is unprecedented in the UK and has been made possible by our dedicated supporters and fundraisers around the country.”
The programmes The Brain Tumour Charity are funding are based at five leading UK centres:
Finding new treatments for aggressive childhood brain tumours
Newcastle University, University College London Institute of Child Health, Institute of Cancer Research
Researchers will use cutting-edge screening techniques to identify critical genetic and biochemical features of aggressive childhood brain tumours. The tumour characteristics they find will be used to develop new treatments that are tailored more closely to the patient.
Targeting brain tumours with ‘cancer-killing’ viruses
University of Leeds
The team at the University of Leeds hopes to harness the power of certain viruses that can kill cancerous cells without harming healthy ones. Such viruses target and ‘invade’ tumour cells, multiplying inside the invaded cell until it bursts and is destroyed.
Unwrapping genes to find new treatments
University College London (UCL) Samantha Dickson Brain Cancer Unit
Building on the work we have funded at our Samantha Dickson Brain Cancer Unit at the UCL Cancer Institute since 2009, the team will be exploring the make-up of brain tumour cells to understand why they multiply so rapidly and often resist treatments. The aim is to find molecular targets that could be targeted by new or existing drugs to halt tumour growth.